Tamer Mohamed, founder and CEO at Aspect Biosystems, joins BNN Bloomberg to discuss their Vancouver-based company, which uses bioprinted tissue to treat currently incurable diseases. Mohamed discusses their partnership with Novo Nordisk and how he hopes to change the future of cell therapy.